The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
Ben Davison, NHS Digital’s Executive Director for Product Development, explains how the coronavirus pandemic prompts a surge in the number of people using NHS tech in 2020.
Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.
Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.
George Atalla, EY Global Government & Infrastructure Leader, explores the effect that COVID-19 has had on the use of data and technology in healthcare.
Diffuse Intrinsic Pontine Glioma (DIPG) is an incurable childhood cancer that has no effective treatment - but now, scientists in Australia believe they have found a drug that could begin to treat this cancer.
The Lancet report is out today (11 February), which suggests that former President Trump's policymaking created an excess of "461,100 deaths" - before the COVID-19 pandemic hit the United States.
Researchers at the Medical College of Georgia have found a potential connection between the experience of unpredictable stress and the function of neurons that can trigger depression.
The legislative changes in the white paper released today (11 February) include giving local and central Government more control over the NHS - which is expected to be implemented in 2022.
The World Health Organisation have suggested that the Oxford and AstraZeneca vaccine can be safely used for all age groups, including those aged 65 and over.
New research by the American Heart Association finds that obesity is a factor in almost half of all new cases, with obese individuals significantly more likely to get Type 2 diabetes.
Edward Belgeonne, founder, & CEO Bantham Technologies, discusses how innovative technology is key to hitting net-zero and creating more time to care in the NHS.
The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.
